Anti-infective coated central venous catheters: Technical aspects and clinical studies;Les cathéters veíneux centraux ímprégné s de substances anti-infectieuses: Aspects techniques et études cliniques

Journal de Pharmacie Clinique

Volumn 22, Issue 3, 2003, Pages 159-167

  Bougle, C ^a   Leroyer, R ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

Antibiotic; Antiseptic; Catheter related infection; Central venous catheters; Coating

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BENZALKONIUM; CEFAZOLIN; CEFUROXIME; CHLORHEXIDINE; CIPROFLOXACIN; CLINDAMYCIN; DICLOXACILLIN; FUSIDIC ACID; GLYCOPEPTIDE; HEPARIN; MINOCYCLINE; RIFAMPICIN; SILVER; SULFADIAZINE SILVER; TEICOPLANIN; VANCOMYCIN;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CONTAMINATION; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG COATING; DRUG EFFICACY; HOSPITAL COST; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; META ANALYSIS; MORBIDITY; MORTALITY; MULTICENTER STUDY; NONHUMAN; PATHOGENESIS; PRACTICE GUIDELINE; RANDOMIZED CONTROLLED TRIAL; SILVER IMPREGNATION; TECHNIQUE;

EID: 0142178145     PISSN: 02911981     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Bleichner G, Beaucaire G, Gottot S, et al. Infections liées aux cathéters veineux centraux en réanimation. Conférence de consensus de la Société de Réanimation de Langue Française. Réan Urg 1994; 3: 321-30.
2. Hulliger S, Pittet D. Incidence, morbidité et mortalité des infections dues aux cathéters veineux centraux en réanimation. Réan Urg 1994; 3: 365-9.
3. Bach A, Eberhardt H, Frick A, Schmidt H, Bottinger BW, Martin E. Efficacy of silver-coating central venous catheters in reducing bacterial colonization. Crit Care Med 1999; 27: 515-21.
4. Mimoz O, Rayeh F, Debaene B. Infections liées aux cathéters veineux en réanimation. Physiopathologie, diagnostic, traitement et prévention. Ann Fr Anesth Réan 2001; 20: 520-36.
5. Brun-Buisson C. Analyse critique des méthodes diagnostiques d'infection liée au cathéter sur matériel enlevé. Réan Urg 1994; 3: 343-6.
6. Dupon M. Epidémiologie des infections sur cathéters veineux centraux et dispositifs implantables. Revue de l'Adphso 1997; 22: 83-7.
7. Merle V, Germain J, Julie S et al. Réduction du taux d'infections liées aux cathéters veineux centraux après l'introduction d'un protocole de soins. HygièneS 1998; 6: 265-9.
8. Armstrong CW, Mayhall G, Miller KB. Prospective study of catheter replacement and other risk factors for infection of hyperalimentation catheters. J Infect Dis 1986; 154: 808-16.
9. Elliott J, Tebbs E. Prevention of central venous catheter-related infection. J Hosp Infect 1998; 40: 193-201.
10. Maki DG, Botticelli JT, Leroy ML, et al. Prospective study of replacement administration sets for intravenous therapy at 48 vs 72 hours intervals. JAMA 1987; 258: 1777-81.
11. O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki MG. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol 2002; 23: 759-69.
12. Di Costanzo J. Prévention de l'infection liée aux cathéters veineux centraux en réanimation. Réan Urg 1994; 3: 385-91.
13. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351: 893-8.
14. Van Der Auwera P. Est-il possible de modifier favorablement l'interaction entre micro-organismes et matériaux? Réan Urg 1994; 3: 393-6.
15. Kamal GD, Pfaller MA, Rempe LE, Jebson PJR. Reduced intravascular catheter infection by antibiotic bonding. A prospective, randomized, controlled trial. JAMA 1991; 265: 2364-8.
16. Trooskin SZ, Donetz AP, Harvey RA, Greco RS. Prevention of catheter sepsis by antibiotic bonding. Surgery 1985; 97: 547-51.
17. Sheretz RJ, Carruth WA, Hampton AA, Byron MP, Solomon DD. Efficacy of antibiotic-coated catheter in preventing subcutaneous Staphylococcus aureus infection in rabbit. J Infect Dis 1993; 167: 98-106.
18. Sheretz RJ, Forman DM, Solomon DD. Efficacy of dicloxacillin-coated polyurethane catheter in preventing subcutaneous Staphylococcus aureus infection in mice. Antimicrob Agents Chemother 1989; 33: 1174-8.
19. Haberer JP. Cathéter veineux central intégrant un matériau antibactérien. Cah Anesthesiol 1999; 47: 263-4.
20. Sioshansi P. Process for surface treatment of catheter. Artif Organs 1994; 18: 266-71.
21. Bambauer R, Mestres P, Pirrung KJ, Sioshansi P. Scanning electron microscopic investigation of catheters for blood access. Artif Organs 1994; 18: 272-5.
22. Bambauer R, Mestres P, Schiel R. Surface treated large bore catheters with silver based coatings versus untreated catheters for extracorporeal detoxification methods. ASAIO J 1998; 44: 303-8.
23. Bambauer R, Mestres P, Schiel R. Surface treated catheters with ion beam process for blood access. Ther Apher 2000; 4: 342-7.
24. Bambauer R, Mestres P, Schiel R, Schneidewind-Muller JM, Bamba S. Large bore catheters with surface treatment versus untreated catheters for blood access. J Vasc Access 2001; 2: 97-105.
25. th interscience conference on antimicrobial agents and chemotherapy - San Diego -. Washington: American Society of Microbiology, 1998: 542.
26. Trerotola SO, Jhonson MS, Shah H. Tunnelled hemodialysis catheters: use of a silver-coated catheter for prevention of infection, a randomized study. Radiology 1998; 207: 491-6.
27. Stoiser B, Kofler J, Staudinger T, et al. Contamination of central venous catheters in immunocompromised patients: a comparison between two different types of central venous catheters. J Hosp Inf 2002; 50: 202-6.
28. Schierholtz JM, Lucas LJ, Rump A, Pulverer G. Efficacy of silver-coated medical devices. J Hosp Infect 1998; 40: 257-62.
29. Williams RL, Williams DF. Albumin adsorption on metal surface. Biomat 1988; 9: 206.
30. Moss HA, Tebbs SE, Faroqui MH, et al. A central venous catheter coated with benzalkonium chloride for the prevention of catheter-related microbial colonization. Eur J Anesthesiol 2000; 17: 680-7.
31. Greco RS, Harvey RA. The rôle of antibiotic bonding in the prevention of vascular prosthetic infections. Ann Surg 1982; 2: 168-71.
32. Civetta JM, Hudson-Civetta J, Ball S. Decreasing catheter-related infection and hospital costs by continuous quality improvement. Crit Care Med 1996; 24: 1660-5.
33. Bach A, Schmidt H, Bottiger B, Schreiber B, Motsch J, Martin E. Reduction in bacterial colonization of triple-lumen catheters with antiseptic bonding in septic patients (abstract). Anesthesiology 1994; 81: 261.
34. George SJ, Vuddamalay P, Boscoe MJ. Antiseptic-impregnated central venous catheters reduce the incidence of bacterial colonization and associated infection in immunocompromised transplant patients. Eur J Anesthesiol 1997; 14: 428-31.
35. Hannan M, Juste RN, Umasanker S, Glendenning A, Nightingale C, Azadian B. Antiseptic-bonded central venous catheters and bacterial colonization. Anesthesia 1999; 54: 868-72.
36. Logghe C, Van Ossel C, D'Hoore W, Ezzedine H, Wauters G, Haxhe JJ. Evaluation of chlorhexidine and silver-sulfadiazine impregnated central venous catheters for the prevention of bloodstream infection in leukaemic patients: a randomized controlled trial. J Hosp Infect 1997; 37: 145-56.
37. Ramsay J, Nolte F, Schwarzmann S. Incidence of catheter colonization and catheter-related infection with an antiseptic-impregnated triple-lumen catheter (abstract). Crit Care Med 1994; 22: A115.
38. Tennenberg S, Lieser M, McCurdy B, Boomer G, Howington E, Newman C. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in prevention of catheter-related bloodstream infections. Arch Surg 1997; 132: 1348-51.
39. Maki DG, Wheeler SJ, Stolz SM. Study of a novel antiseptic coated central venous catheter. Antimicrob Agents Chemother 1991; 19: S99.
40. Xu QA, Zhang Y, Trissel LA, Gilbert DL. Adequacy of a new chlorhexidine-bearing polyurethane central venous catheter for administration of 82 selected parenteral drugs. Ann Pharmacother 2000; 34: 1109-16.
41. Toshiyuki O, Junichiro H, Naomi K, Mikami K. Anaphylactic shock induced by an antiseptic-coated central venous catheter. Anesthesiology 1997; 87: 1242-4.
42. Kessler LG. FDA alert: hypersensibility reactions to central venous catheters. American Society of Anesthesiologists Newsletter 1998; 62: 24-5.
43. Maki DG, Stoltz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. Ann Intern Med 1997; 127: 257-66.
44. Bach A, Darby D, Bottiger B, Bohrer H, Motsch J, Martin E. Retention of the antibiotic teicoplanin on a hydromer-coated central venous catheter to prevent bacterial colonization in postoperative surgical patients. Intensive Care Med 1996; 22: 1066-9.
45. Thornton J, Todd NJ, Webster NR. Central venous line sepsis in the intensive care unit. A study comparing antibiotic coated catheters with plain catheters. Anesthesia 1996; 51: 1018-20.
46. Raad I, Darouiche R, Dupuis J. Central venous catheters coated with minocycline and rifampicin for the prevention of catheter-related colonization and bloodstream infections. Ann Intern Med 1997; 127: 267-74.
47. Darouiche R, Raad I, Stephen OH.A comparison of two antimicrobial-impregnated central venous catheters. N Engl J Med 1999; 340: 1-8.
48. Raad I, Darouiche R, Hachem R, Abi-Said D, Safar H, Darnule T. Antimicrobial durability and rare ultrastructural colonization of indwelling central catheters coated with minocycline and rifampicin. Crit Care Med 1998; 26: 219-24.
49. Tambe SM, Sampath L, Modak SM. In vitro evaluation of the risk of developping resistance to antiseptics and antibiotics used in medical devices. J Antimicrob Chemother 2001; 47: 589-98.
50. Bach A, Schmidt H, Bottiger B, Schreiber B, Bohrer H, Motsch J. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996; 37: 315-22.
51. Ciresi DL, Albrecht RM, Volkers PA, Scholten DJ. Failure of antiseptic bonding to prevent central venous catheter-related infection and sepsis. Am Surg 1996; 62: 641-6.
52. Collin G. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project. Chest 1999; 115: 1632-40.
53. Goldschmidt H, Hahn U, Salwender HJ, Haas R, Jansen B, Wolbring P. Prevention of catheter-related infections by silver-coated central venous catheters in oncological patients. Zentralbl Bakteriol 1995; 283: 215-23.
54. Heard SO, Wagle M, Vijayakumar E, McLean S, Brueggeman A, Napolitano LM. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med 1998; 158: 81-7.
55. Jaeger K, Osthaus A, Heine J, et al. Efficacy of a benzalkonium chloride-impregnated central venous catheter to prevent catheter-associated infection in cancer patients. Chemother 2001; 47: 50-5.
56. Kamal GD, Divishek D, Kumar GC, Porter BR, Tatman DJ, Adams JR. Reduced intravascular catheter-related infection by routine use of antibiotic-bonded catheters in surgical intensive care unit. Diagn Microbiol Infect Dis 1998; 30: 145-52.
57. Leonard A. Prevention of intravascular catheter-related infection. Ann Intern Med 2000; 132: 391-402.
58. Loo S, Van Heerden PV, Gollege CL, Roberts BL, Power BM. Infection in central lines: antiseptic-impregnated vs standard non-impregnated catheters. Anaesth Intensive Care 1997; 25: 637-9.
59. Marik PE, Abraham G, Careau P, Varon J, Fromm R. The ex vivo antimicrobial activity and colonization rate of two antimicrobial-bonded central venous catheters. Crit Care Med 1999; 27: 1128-31.
60. Nitenberg G, Brun-Buisson C, Doyon F, et al. Randomized controlled trial of antiseptic-coated (ACC) central venous catheters (CVC) Etude multi-centrique française 2002. Résultats non publiés.
61. Pemberton LB, Ross V, Cuddy P, Kremer H, Fessler T, McGurk E. No difference in catheter sepsis between standard and antiseptic central venous catheters. Arch Surg 1996; 131: 986-9.
62. Saint S, Veenstra DL, Lipsky BA. The clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheter useful? Infect Control Hosp Epidemiol 2000; 21: 375-80.
63. Sheng W, Ko W, Wang J, Chang S, Hsueh P, Luh K. Evaluation of antiseptic central venous catheters for the prevention of catheter-related infection in intensive care unit patients. Diagn Microbiol Infect Dis 2000; 3 8: 1-5.
64. Trazzera S, Stern G, Bhardway R, Sinha S, Reiser P. Examination of antimicrobial-coated central venous catheters in patients at high risk for catheter-related infections in a medical intensive care unit and leukemia/bone marrow transplant unit. Crit Care Med 1995; 23: A153.
65. Van Heerden PV, Webb SA, Fong S, Golledge CL, Roberts BL, Thompson WR. Central venous catheters revisited infections rates and an assessment of the new fibrin analysing system brush. Anaesth Intensive Care 1996; 24: 330-3.
66. Walder B, Pittet D, Tramer MR. Prevention of bloodstream infections with central venous catheters treated with anti-effective agents depends on catheter type and insertion time: evidence from a meta-analysis. Infect Cont Hosp Epidemiol 2002; 13: 748-56.